Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway – A register study
Results suggest increased risk of CHD in FH relative to controls, but measures are imprecise because of low absolute risks. Compliance with lipid lowering therapy was moderate.
Authors
- Emil Andreas Asprusten (ORCID: https://orcid.org/0009-0005-9075-3296)
- Kjetil Retterstøl (ORCID: https://orcid.org/0000-0002-1309-7556)
- Jannicke Igland (ORCID: https://orcid.org/0000-0002-2289-0978)
- Kirsten B. Holven (ORCID: https://orcid.org/0000-0002-8674-9703)
- Gisle Langslet (ORCID: https://orcid.org/0000-0003-4034-2243)
- Martin P. Bogsrud (ORCID: https://orcid.org/0000-0002-2321-2490)
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Western Norway University of Applied Sciences (NO)
- University of Bergen (NO)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.ajpc.2025.101043
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Direktør Throne Holsts Fond For Ernæringsforskning
- Helse Sør-Øst RHF